Committed to innovative surgical solutions US · English ▾
Contact us

Resources

About Us

We are developing next-generation, advanced surgical solutions

Innoblative, a private medical device company addressing clinical unmet needs for patients with breast cancer and other soft tissue disease, received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA) for the company's SIRA® RFA Electrosurgical Device.

To learn more, click on one of the following items

FDA Breakthrough Device Designation press release
FDA 510k clearance letter
BCS + RFA

Instructions for Use

SIRA-1000 IFU
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.